Telomir Pharmaceuticals TELO
NASDAQ TELO
$1.20 +0.03 (+2.56%)
At close: Sep 30, 2026 · 4:00 PM EDT

Telomir Pharmaceuticals (TELO) Long-Term Debt Repayments (2023 - 2024)

Updated

Telomir Pharmaceuticals (TELO) recorded Long-Term Debt Repayments of -$85,529 in Q3 2024.

Analysis

Telomir Pharmaceuticals (TELO) Long-Term Debt Repayments (2023 - 2024) Analysis & Trends

On a TTM basis, Telomir Pharmaceuticals' Long-Term Debt Repayments came in at $751,335 as of Sep 30, 2024.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 2.00 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 5.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.45 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 17.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Telomir Pharmaceuticals 82.53 Mn 82.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -85,529.00
Mar 31, 2024 519,475.00
Jun 30, 2023 317,389.00
Mar 31, 2023 263,873.00
API Access

Telomir Pharmaceuticals Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=TELO&period=max&api_key=YOUR_API_KEY